Christopher A. Guerreiro

Christopher A. Guerreiro

ID: 1b83600d-2619-30fb-68c4

/

Claimed Record

/

Organization: Norton Rose Fulbright

Supreme Court of Canada grants leave to appeal methods of medical treatment patentability decision

Pharma in Brief · September 19, 2024

Federal Court addresses treatment and formulation patent claims in PMNOC case

Pharma in Brief · August 27, 2024

British Columbia signs first funding agreement under the national rare disease strategy

Pharma in Brief · August 18, 2024

Drug pricing: PMPRB launches next phase of the Guidelines consultation

Pharma in Brief · June 28, 2024

CADTH to Transform into Canada’s Drug Agency

Pharma in Brief · May 6, 2024

Practice Areas

Health Care and Life Sciences

Intellectual Property

Jurisdictions